Concentrated Nordic bilberries. Supports vision and health with high-purity anthocyanins.
This product is a high-quality berry extract made from fully ripe bilberries (Vaccinium myrtillus L.) harvested in Sweden, Latvia, and Russia. It utilizes ion exchange resin columns and spray-drying technology to extract and powder polyphenols at a high concentration. It contains over 25% anthocyanidins as measured by UV-VIS method and over 36% anthocyanins as measured by HPLC method. Through high-purification processing, sugars are removed, achieving excellent antioxidant power and stability. It is ideal for health food and supplement applications, supporting visual function, improving blood flow, and providing antioxidant and anti-inflammatory effects. It has also obtained numerous international certifications, making it a safe and high-quality natural material for a wide range of uses.
Inquire About This Product
basic information
- Raw materials: Bilberry (Vaccinium myrtillus L.) - Appearance: Dark reddish-purple, hygroscopic amorphous powder - Anthocyanidin: 25% or more (UV-VIS) - Anthocyanin: 36% or more (HPLC) - Loss on drying: 4.5% or less - Ash content: 2.0% or less - Particle size: 80 mesh or more (180μm, transmittance 95% or more) - Microbiology: Aerobic bacteria 1,000 cfu/g or less, yeast and mold 100 cfu/g or less, E. coli/Salmonella negative - Heavy metals: As 1.0 ppm or less, Pb 0.5 ppm or less, Cd 1.0 ppm or less, Hg 0.1 ppm or less - Packaging: 20 kg polyethylene-aluminum bag/box - Country of origin: Latvia - Shelf life: 3 years after production - Certifications: Organic, FSSC 22000, ISO 14001, Kosher, UEBT, Bio Suisse
Price range
Delivery Time
Applications/Examples of results
Nutritional supplements (tablets, capsules, granules, drinks, gels, etc.)
catalog（1）
Download All Catalogs
Company information
Rivason Co., Ltd. is a company located in Chuo Ward, Osaka City, engaged in the sale of functional materials, contract organic synthesis, biocides, machinery export and import, sale of pharmaceutical raw materials and intermediates, sale of functional food ingredients, sale of cosmetic ingredients, overseas contract manufacturing of pharmaceuticals, and pharmaceutical business operations.